1
|
Ahmad MS, Minaee N, Serrano-Contreras JI, Kaluarachchi M, Shen EYL, Boulange C, Ahmad S, Phetcharaburanin J, Holmes E, Wist J, Albaloshi AH, Alaama T, Damanhouri ZA, Lodge S. Exploring the Interactions between Obesity and Diabetes: Implications for Understanding Metabolic Dysregulation in a Saudi Arabian Adult Population. J Proteome Res 2024; 23:809-821. [PMID: 38230637 PMCID: PMC10846529 DOI: 10.1021/acs.jproteome.3c00717] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Revised: 12/07/2023] [Accepted: 12/14/2023] [Indexed: 01/18/2024]
Abstract
The rising prevalence of obesity in Saudi Arabia is a major contributor to the nation's high levels of cardiometabolic diseases such as type 2 diabetes. To assess the impact of obesity on the diabetic metabolic phenotype presented in young Saudi Arabian adults, participants (n = 289, aged 18-40 years) were recruited and stratified into four groups: healthy weight (BMI 18.5-24.99 kg/m2) with (n = 57) and without diabetes (n = 58) or overweight/obese (BMI > 24.99 kg/m2) with (n = 102) and without diabetes (n = 72). Distinct plasma metabolic phenotypes associated with high BMI and diabetes were identified using nuclear magnetic resonance spectroscopy and ultraperformance liquid chromatography mass spectrometry. Increased plasma glucose and dysregulated lipoproteins were characteristics of obesity in individuals with and without diabetes, but the obesity-associated lipoprotein phenotype was partially masked in individuals with diabetes. Although there was little difference between diabetics and nondiabetics in the global plasma LDL cholesterol and phospholipid concentration, the distribution of lipoprotein particles was altered in diabetics with a shift toward denser and more atherogenic LDL5 and LDL6 particles, which was amplified in the presence of obesity. Further investigation is warranted in larger Middle Eastern populations to explore the dysregulation of metabolism driven by interactions between obesity and diabetes in young adults.
Collapse
Affiliation(s)
- Muhammad Saeed Ahmad
- Department
of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, U.K.
- Drug
Metabolism Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
| | - Novia Minaee
- Health
Futures Institute, Murdoch University, Perth, WA 6150, Australia
| | | | - Manuja Kaluarachchi
- Department
of Metabolism, Digestion and Reproduction, Imperial College, London SW7 2AZ, U.K.
| | - Eric Yi-Liang Shen
- Department
of Metabolism, Digestion and Reproduction, Imperial College, London SW7 2AZ, U.K.
- Department
of Radiation Oncology, Chang Gung Memorial
Hospital and Chang Gung University, Taoyuan 333, Taiwan
| | - Claire Boulange
- Department
of Metabolism, Digestion and Reproduction, Imperial College, London SW7 2AZ, U.K.
| | - Sultan Ahmad
- Drug
Metabolism Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
| | - Jutarop Phetcharaburanin
- Department
of Systems Biosciences and Computational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
| | - Elaine Holmes
- Health
Futures Institute, Murdoch University, Perth, WA 6150, Australia
- Department
of Metabolism, Digestion and Reproduction, Imperial College, London SW7 2AZ, U.K.
| | - Julien Wist
- Health
Futures Institute, Murdoch University, Perth, WA 6150, Australia
- Department
of Metabolism, Digestion and Reproduction, Imperial College, London SW7 2AZ, U.K.
- Chemistry
Department, Universidad del Valle, Cali 76001, Colombia
| | - Ahmed Hakem Albaloshi
- King
Abdulaziz Hospital and Endocrine and Diabetic Center, Jeddah 23436, Saudi Arabia
| | - Tareef Alaama
- Department
of Medicine, Faculty of Medicine, King Abdulaziz
University, Jeddah 21589, Saudi Arabia
| | - Zoheir Abdullah Damanhouri
- Drug
Metabolism Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
- Department
of Pharmacology, Faculty of Medicine, King
Abdulaziz University, Jeddah 21589, Saudi Arabia
| | - Samantha Lodge
- Health
Futures Institute, Murdoch University, Perth, WA 6150, Australia
| |
Collapse
|
2
|
Climaco Pinto R, Karaman I, Lewis MR, Hällqvist J, Kaluarachchi M, Graça G, Chekmeneva E, Durainayagam B, Ghanbari M, Ikram MA, Zetterberg H, Griffin J, Elliott P, Tzoulaki I, Dehghan A, Herrington D, Ebbels T. Finding Correspondence between Metabolomic Features in Untargeted Liquid Chromatography-Mass Spectrometry Metabolomics Datasets. Anal Chem 2022; 94:5493-5503. [PMID: 35360896 PMCID: PMC9008693 DOI: 10.1021/acs.analchem.1c03592] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
![]()
Integration
of multiple datasets can greatly enhance bioanalytical
studies, for example, by increasing power to discover and validate
biomarkers. In liquid chromatography–mass spectrometry (LC–MS)
metabolomics, it is especially hard to combine untargeted datasets
since the majority of metabolomic features are not annotated and thus
cannot be matched by chemical identity. Typically, the information
available for each feature is retention time (RT), mass-to-charge
ratio (m/z), and feature intensity
(FI). Pairs of features from the same metabolite in separate datasets
can exhibit small but significant differences, making matching very
challenging. Current methods to address this issue are too simple
or rely on assumptions that cannot be met in all cases. We present
a method to find feature correspondence between two similar LC–MS
metabolomics experiments or batches using only the features’
RT, m/z, and FI. We demonstrate
the method on both real and synthetic datasets, using six orthogonal
validation strategies to gauge the matching quality. In our main example,
4953 features were uniquely matched, of which 585 (96.8%) of 604 manually
annotated features were correct. In a second example, 2324 features
could be uniquely matched, with 79 (90.8%) out of 87 annotated features
correctly matched. Most of the missed annotated matches are between
features that behave very differently from modeled inter-dataset shifts
of RT, MZ, and FI. In a third example with simulated data with 4755
features per dataset, 99.6% of the matches were correct. Finally,
the results of matching three other dataset pairs using our method
are compared with a published alternative method, metabCombiner, showing
the advantages of our approach. The method can be applied using M2S
(Match 2 Sets), a free, open-source MATLAB toolbox, available at https://github.com/rjdossan/M2S.
Collapse
Affiliation(s)
- Rui Climaco Pinto
- Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W12 0BZ, U.K.,UK Dementia Research Institute, Imperial College London, London W12 0BZ, U.K
| | - Ibrahim Karaman
- Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W12 0BZ, U.K.,UK Dementia Research Institute, Imperial College London, London W12 0BZ, U.K
| | - Matthew R Lewis
- MRC-NIHR National Phenome Centre, Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, U.K.,Section of Bioanalytical Chemistry, Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, U.K
| | - Jenny Hällqvist
- Centre for Translational Omics, Great Ormond Street Hospital, University College London, London WC1N 1EH, U.K.,Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London WC1N 3BG, U.K
| | - Manuja Kaluarachchi
- UK Dementia Research Institute, Imperial College London, London W12 0BZ, U.K.,Section of Bioinformatics, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, U.K
| | - Gonçalo Graça
- Section of Bioinformatics, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, U.K
| | - Elena Chekmeneva
- MRC-NIHR National Phenome Centre, Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, U.K.,Section of Bioanalytical Chemistry, Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, U.K
| | - Brenan Durainayagam
- Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W12 0BZ, U.K.,UK Dementia Research Institute, Imperial College London, London W12 0BZ, U.K
| | - Mohsen Ghanbari
- Department of Epidemiology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | - M Arfan Ikram
- Department of Epidemiology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | - Henrik Zetterberg
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, 431 41 Mölndal, Sweden.,Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 413 45 Mölndal, Sweden.,Department of Neurodegenerative Disease, University College London, Queen Square, London WC1N 3BG, U.K.,UK Dementia Research Institute, University College London, London WC1N 3BG, U.K
| | - Julian Griffin
- UK Dementia Research Institute, Imperial College London, London W12 0BZ, U.K.,Section of Bioinformatics, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, U.K
| | - Paul Elliott
- Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W12 0BZ, U.K.,UK Dementia Research Institute, Imperial College London, London W12 0BZ, U.K
| | - Ioanna Tzoulaki
- Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W12 0BZ, U.K.,Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, 451 10 Ioannina, Greece
| | - Abbas Dehghan
- Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W12 0BZ, U.K.,UK Dementia Research Institute, Imperial College London, London W12 0BZ, U.K.,Department of Epidemiology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | - David Herrington
- Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina 27101, United States
| | - Timothy Ebbels
- Section of Bioinformatics, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, U.K
| |
Collapse
|
3
|
Wood AC, Saylor G, Tzoulaki I, Greenland P, Tracy RP, Post WS, Lindon J, Wassel CL, Phan M, Momin S, Ebbels T, Boulange C, Graça G, Karaman I, Gadghil M, Chekmeneva E, Kaluarachchi M, Elliott P, Herrington DM. Abstract MP09: Untargeted
1
H Nmr Metabolomics Metabolomic Analysis Reveals Pathways Of Protection Between Mediterranean-style Diet And Incident Cardiovascular Disease In The Multi-ethnic Study Of Atherosclerosis. Circulation 2021. [DOI: 10.1161/circ.143.suppl_1.mp09] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background:
The metabolites associated with a Mediterranean-style (AMED) diet may give insight into why AMED is robustly associated with protection against CVD. Previous investigations seeking to identify these have been limited by the use of modest sample sizes and targeted assays.
Methods:
Using samples from the Multi-Ethnic Study of Atherosclerosis (MESA), we conducted untargeted
1
H NMR spectroscopy (600 MHz) with internal and external annotation on the sera of ~3,698 participants, ages 45-84, who were free from overt CVD. We included data on baseline dietary intake (self-reported), and all incident CVD events (excluding stroke) over a 10-year period. From >100,000 spectral features, 845 significant associations (P<2.2*10
-6
) were identified via linear regression, and reduced to a putative list of 46 via elastic net regularized models. Hierarchical clustering identified 11 feature groups, from which cluster scores were constructed. The ‘mediate’ package in R used bootstrapping (1000 simulations) to partition the association between AMED and incident CVD into the effects of dietary intake on CVD which are mediated by the metabolomic cluster scores (the “indirect” / mediated effects) and those effects which are not (“direct effects”). All association analyses controlled for age, sex, ethnicity, data collection site and daily caloric intake.
Results:
AMED score was associated with reductions in the incidence of CVD (HR=0.95; 95% CI: 0.91 - 0.99; P=0.02). All metabolomic cluster scores were associated with AMED (all P<2*10
-06
;
Table 1
), with 6 significantly associated with incident CVD (all P<2.0*10
-4
) in the expected direction given their associations with AMED score. Four of these six significantly mediated the association of AMED score with incident CVD (P<0.05;
Table 1
).
Conclusions:
These preliminary data suggest that specific molecules, if replicated in other studies, hold promise to identify the underlying pathways by which an AMED diet offers protection against CVD.
Collapse
|
4
|
Qureshi M, Vorkas P, Kaluarachchi M, Holmes E, Davies AH. Metabolic Profiling of Carotid Atherosclerosis. Eur J Vasc Endovasc Surg 2019. [DOI: 10.1016/j.ejvs.2019.06.1214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
5
|
Seow WJ, Shu XO, Nicholson JK, Holmes E, Walker DI, Hu W, Cai Q, Gao YT, Xiang YB, Moore SC, Bassig BA, Wong JYY, Zhang J, Ji BT, Boulangé CL, Kaluarachchi M, Wijeyesekera A, Zheng W, Elliott P, Rothman N, Lan Q. Association of Untargeted Urinary Metabolomics and Lung Cancer Risk Among Never-Smoking Women in China. JAMA Netw Open 2019; 2:e1911970. [PMID: 31539079 PMCID: PMC6755532 DOI: 10.1001/jamanetworkopen.2019.11970] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
IMPORTANCE Chinese women have the highest rate of lung cancer among female never-smokers in the world, and the etiology is poorly understood. OBJECTIVE To assess the association between metabolomics and lung cancer risk among never-smoking women. DESIGN, SETTING, AND PARTICIPANTS This nested case-control study included 275 never-smoking female patients with lung cancer and 289 never-smoking cancer-free control participants from the prospective Shanghai Women's Health Study recruited from December 28, 1996, to May 23, 2000. Validated food frequency questionnaires were used for the collection of dietary information. Metabolomic analysis was conducted from November 13, 2015, to January 6, 2016. Data analysis was conducted from January 6, 2016, to November 29, 2018. EXPOSURES Untargeted ultra-high-performance liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance metabolomic profiles were characterized using prediagnosis urine samples. A total of 39 416 metabolites were measured. MAIN OUTCOMES AND MEASURES Incident lung cancer. RESULTS Among the 564 women, those who developed lung cancer (275 participants; median [interquartile range] age, 61.0 [52-65] years) and those who did not develop lung cancer (289 participants; median [interquartile range] age, 62.0 [53-66] years) at follow-up (median [interquartile range] follow-up, 10.9 [9.0-11.7] years) were similar in terms of their secondhand smoke exposure, history of respiratory diseases, and body mass index. A peak metabolite, identified as 5-methyl-2-furoic acid, was significantly associated with lower lung cancer risk (odds ratio, 0.57 [95% CI, 0.46-0.72]; P < .001; false discovery rate = 0.039). Furthermore, this peak was weakly correlated with self-reported dietary soy intake (ρ = 0.21; P < .001). Increasing tertiles of this metabolite were associated with lower lung cancer risk (in comparison with first tertile, odds ratio for second tertile, 0.52 [95% CI, 0.34-0.80]; and odds ratio for third tertile, 0.46 [95% CI, 0.30-0.70]), and the association was consistent across different histological subtypes and follow-up times. Additionally, metabolic pathway analysis found several systemic biological alterations that were associated with lung cancer risk, including 1-carbon metabolism, nucleotide metabolism, oxidative stress, and inflammation. CONCLUSIONS AND RELEVANCE This prospective study of the untargeted urinary metabolome and lung cancer among never-smoking women in China provides support for the hypothesis that soy-based metabolites are associated with lower lung cancer risk in never-smoking women and suggests that biological processes linked to air pollution may be associated with higher lung cancer risk in this population.
Collapse
Affiliation(s)
- Wei Jie Seow
- Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland
| | - Xiao-Ou Shu
- Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
| | - Jeremy K. Nicholson
- Biomolecular Medicine, Division of Computational and Systems Medicine, Medical Research Council–National Institute for Health Research National Phenome Centre, Imperial College London, United Kingdom
- Medical Research Council–PHE Centre for Environment and Health, Department of Surgery and Cancer, Imperial College London, United Kingdom
- Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia
| | - Elaine Holmes
- Biomolecular Medicine, Division of Computational and Systems Medicine, Medical Research Council–National Institute for Health Research National Phenome Centre, Imperial College London, United Kingdom
- Medical Research Council–PHE Centre for Environment and Health, Department of Surgery and Cancer, Imperial College London, United Kingdom
- Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia
| | - Douglas I. Walker
- Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Wei Hu
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland
| | - Qiuyin Cai
- Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
| | - Yu-Tang Gao
- Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China
| | - Yong-Bing Xiang
- Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China
- State Key Laboratory of Oncogene and Related Genes, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Steven C. Moore
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland
| | - Bryan A. Bassig
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland
| | - Jason Y. Y. Wong
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland
| | - Jinming Zhang
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland
| | - Bu-Tian Ji
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland
| | - Claire L. Boulangé
- Biomolecular Medicine, Division of Computational and Systems Medicine, Medical Research Council–National Institute for Health Research National Phenome Centre, Imperial College London, United Kingdom
- Medical Research Council–PHE Centre for Environment and Health, Department of Surgery and Cancer, Imperial College London, United Kingdom
| | - Manuja Kaluarachchi
- Biomolecular Medicine, Division of Computational and Systems Medicine, Medical Research Council–National Institute for Health Research National Phenome Centre, Imperial College London, United Kingdom
- Medical Research Council–PHE Centre for Environment and Health, Department of Surgery and Cancer, Imperial College London, United Kingdom
| | - Anisha Wijeyesekera
- Biomolecular Medicine, Division of Computational and Systems Medicine, Medical Research Council–National Institute for Health Research National Phenome Centre, Imperial College London, United Kingdom
- Medical Research Council–PHE Centre for Environment and Health, Department of Surgery and Cancer, Imperial College London, United Kingdom
| | - Wei Zheng
- Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
| | - Paul Elliott
- Biomolecular Medicine, Division of Computational and Systems Medicine, Medical Research Council–National Institute for Health Research National Phenome Centre, Imperial College London, United Kingdom
- Medical Research Council–PHE Centre for Environment and Health, Department of Surgery and Cancer, Imperial College London, United Kingdom
- MRC-PHE Centre for Environment and Health, School of Public Health, Department of Epidemiology and Biostatistics, Imperial College London, United Kingdom
- National Institute for Health Research, Imperial College Biomedical Research Centre, London, United Kingdom
- Health Data Research UK London at Imperial College London, United Kingdom
| | - Nathaniel Rothman
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland
| | - Qing Lan
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland
| |
Collapse
|
6
|
Seow WJ, Shu XO, Nicholson J, Holmes E, Hu W, Cai Q, Gao YT, Xiang YB, Moore S, Bassig BA, Wong JY, Zhang J, Ji BT, Boulange C, Kaluarachchi M, Adesina-Georgiadis KF, Wijeyesekera A, Zheng W, Elliot P, Rothman N, Lan Q. Abstract 4974: Prospective study of untargeted urinary metabolomics and risk of lung cancer among female never-smokers in Shanghai, China. Cancer Res 2018. [DOI: 10.1158/1538-7445.am2018-4974] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
The lung cancer rate among never-smokers is the highest among Asian women, however its etiology and any relevant non-smoking related biomarkers are still unclear. Pre-diagnostic lung cancer-related metabolic biomarkers may provide novel insights into lung cancer mechanisms, and may contribute to the discovery of etiologic factors for the high lung cancer prevalence among Asian women. We evaluated the role of the urinary metabolome in lung cancer development among female never-smokers in China by conducting a nested case-control study of 275 lung cancer cases and 289 healthy controls from the Shanghai Women's Health Study, a prospective cohort comprised of 73,363 Chinese female never-smokers. Metabolic profiling of urinary chemical features was conducted using ultrahigh-performance liquid chromatography - tandem mass spectrometry (UPLC-MS) (39,409 spectral features) and 600 MHz 1H nuclear magnetic resonance (NMR) spectroscopy (386 features). Unconditional logistic regression models were used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for the association between each log-transformed metabolite level and lung cancer risk, adjusting for potential confounders such as age, body mass index, history of respiratory disease and passive smoking. Spearman correlation and linear regression were used to estimate associations between the most significant metabolites and pre-diagnosis dietary factors. Three detected UPLC-MS urinary metabolites were negatively associated with lung cancer risk with a false discovery rate of less than 10%: pos_2.61_127.0382m/z (OR = 0.57, 95% CI = 0.46-0.72, P = 1.98 x 10-6), neg_2.60_369.0408m/z (OR = 0.97, 95% CI = 0.96-0.98, P = 1.36 x 10-6), and pos_2.61_184.0325n (OR = 0.55, 95% CI = 0.43-0.71, P = 4.91 x 10-6). These were strongly correlated with each other (rho > 0.65, p < 0.0001). The significant metabolite (pos_2.61_127.0382m/z) was identified as 5-methyl-2-furoic acid and was moderately correlated with self-reported dietary intake of soy (rho = 0.21, p < 0.001). In conclusion, we identified a metabolite in urine (5-methyl-2-furoic acid) that provides support for the protective association of soy-based foods on lung cancer risk that was previously observed in this population of never-smoking women. Further studies are warranted to replicate these findings.
Citation Format: Wei Jie Seow, Xiao-Ou Shu, Jeremy Nicholson, Elaine Holmes, Wei Hu, Qiuyin Cai, Yu-Tang Gao, Yong-Bing Xiang, Steve Moore, Bryan A. Bassig, Jason Yy Wong, Jinming Zhang, Bu-Tian Ji, Claire Boulange, Manuja Kaluarachchi, Kyrillos F. Adesina-Georgiadis, Anisha Wijeyesekera, Wei Zheng, Paul Elliot, Nathaniel Rothman, Qing Lan. Prospective study of untargeted urinary metabolomics and risk of lung cancer among female never-smokers in Shanghai, China [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 4974.
Collapse
Affiliation(s)
- Wei Jie Seow
- 1National University of Singapore, Singapore, Singapore
| | - Xiao-Ou Shu
- 2Vanderbilt University Medical Center, Nashville, TN
| | | | | | - Wei Hu
- 4National Cancer Institute, Bethesda, MD
| | - Qiuyin Cai
- 2Vanderbilt University Medical Center, Nashville, TN
| | | | | | | | | | | | | | - Bu-Tian Ji
- 4National Cancer Institute, Bethesda, MD
| | | | | | | | | | - Wei Zheng
- 2Vanderbilt University Medical Center, Nashville, TN
| | | | | | - Qing Lan
- 4National Cancer Institute, Bethesda, MD
| |
Collapse
|
7
|
Kaluarachchi M, Boulangé CL, Karaman I, Lindon JC, Ebbels TMD, Elliott P, Tracy RP, Olson NC. A comparison of human serum and plasma metabolites using untargeted 1H NMR spectroscopy and UPLC-MS. Metabolomics 2018; 14:32. [PMID: 30830335 PMCID: PMC7122646 DOI: 10.1007/s11306-018-1332-1] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2017] [Accepted: 01/30/2018] [Indexed: 12/21/2022]
Abstract
INTRODUCTION Differences in the metabolite profiles between serum and plasma are incompletely understood. OBJECTIVES To evaluate metabolic profile differences between serum and plasma and among plasma sample subtypes. METHODS We analyzed serum, platelet rich plasma (PRP), platelet poor plasma (PPP), and platelet free plasma (PFP), collected from 8 non-fasting apparently healthy women, using untargeted standard 1D and CPMG 1H NMR and reverse phase and hydrophilic (HILIC) UPLC-MS. Differences between metabolic profiles were evaluated using validated principal component and orthogonal partial least squares discriminant analysis. RESULTS Explorative analysis showed the main source of variation among samples was due to inter-individual differences with no grouping by sample type. After correcting for inter-individual differences, lipoproteins, lipids in VLDL/LDL, lactate, glutamine, and glucose were found to discriminate serum from plasma in NMR analyses. In UPLC-MS analyses, lysophosphatidylethanolamine (lysoPE)(18:0) and lysophosphatidic acid(20:0) were higher in serum, and phosphatidylcholines (PC)(16:1/18:2, 20:3/18:0, O-20:0/22:4), lysoPC(16:0), PE(O-18:2/20:4), sphingomyelin(18:0/22:0), and linoleic acid were lower. In plasma subtype analyses, isoleucine, leucine, valine, phenylalanine, glutamate, and pyruvate were higher among PRP samples compared with PPP and PFP by NMR while lipids in VLDL/LDL, citrate, and glutamine were lower. By UPLC-MS, PE(18:0/18:2) and PC(P-16:0/20:4) were higher in PRP compared with PFP samples. CONCLUSIONS Correction for inter-individual variation was required to detect metabolite differences between serum and plasma. Our results suggest the potential importance of inter-individual effects and sample type on the results from serum and plasma metabolic phenotyping studies.
Collapse
Affiliation(s)
- Manuja Kaluarachchi
- Metabometrix Ltd, Sir Alexander Fleming Building, Prince Consort Road, London, SW7 1BP, UK
| | - Claire L Boulangé
- Metabometrix Ltd, Sir Alexander Fleming Building, Prince Consort Road, London, SW7 1BP, UK
| | - Ibrahim Karaman
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, W2 1PG, UK
| | - John C Lindon
- Metabometrix Ltd, Sir Alexander Fleming Building, Prince Consort Road, London, SW7 1BP, UK
- Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, London, SW7 2AZ, UK
| | - Timothy M D Ebbels
- Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, London, SW7 2AZ, UK
| | - Paul Elliott
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, W2 1PG, UK
- MRC-PHE Centre for Environment and Health, Imperial College London, London, W2 1PG, UK
| | - Russell P Tracy
- Department of Biochemistry, The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, 05446, USA
- Department of Pathology and Laboratory Medicine, The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, 05446, USA
| | - Nels C Olson
- Department of Pathology and Laboratory Medicine, The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, 05446, USA.
| |
Collapse
|
8
|
Jackson F, Georgakopoulou N, Kaluarachchi M, Kyriakides M, Andreas N, Przysiezna N, Hyde MJ, Modi N, Nicholson JK, Wijeyesekera A, Holmes E. Development of a Pipeline for Exploratory Metabolic Profiling of Infant Urine. J Proteome Res 2016; 15:3432-40. [PMID: 27476583 DOI: 10.1021/acs.jproteome.6b00234] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Numerous metabolic profiling pipelines have been developed to characterize the composition of human biofluids and tissues, the vast majority of these being for studies in adults. To accommodate limited sample volume and to take into account the compositional differences between adult and infant biofluids, we developed and optimized sample handling and analytical procedures for studying urine from newborns. A robust pipeline for metabolic profiling using NMR spectroscopy was established, encompassing sample collection, preparation, spectroscopic measurement, and computational analysis. Longitudinal samples were collected from five infants from birth until 14 months of age. Methods of extraction and effects of freezing and sample dilution were assessed, and urinary contaminants from breakdown of polymers in a range of diapers and cotton wool balls were identified and compared, including propylene glycol, acrylic acid, and tert-butanol. Finally, assessment of urinary profiles obtained over the first few weeks of life revealed a dramatic change in composition, with concentrations of phenols, amino acids, and betaine altering systematically over the first few months of life. Therefore, neonatal samples require more stringent standardization of experimental design, sample handling, and analysis compared to that of adult samples to accommodate the variability and limited sample volume.
Collapse
Affiliation(s)
- Frances Jackson
- Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London , South Kensington Campus, London SW7 2AZ, United Kingdom
| | - Nancy Georgakopoulou
- Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London , South Kensington Campus, London SW7 2AZ, United Kingdom
| | - Manuja Kaluarachchi
- Metabometrix Ltd, Bioincubator, Prince Consort Road, South Kensington, London SW7 2AZ, United Kingdom
| | - Michael Kyriakides
- Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London , South Kensington Campus, London SW7 2AZ, United Kingdom
| | - Nicholas Andreas
- Section of Neonatal Medicine, Department of Medicine, Imperial College London , Chelsea and Westminster Hospital Campus, London SW10 9NH, United Kingdom
| | - Natalia Przysiezna
- Section of Neonatal Medicine, Department of Medicine, Imperial College London , Chelsea and Westminster Hospital Campus, London SW10 9NH, United Kingdom
| | - Matthew J Hyde
- Section of Neonatal Medicine, Department of Medicine, Imperial College London , Chelsea and Westminster Hospital Campus, London SW10 9NH, United Kingdom
| | - Neena Modi
- Section of Neonatal Medicine, Department of Medicine, Imperial College London , Chelsea and Westminster Hospital Campus, London SW10 9NH, United Kingdom
| | - Jeremy K Nicholson
- Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London , South Kensington Campus, London SW7 2AZ, United Kingdom.,MRC-NIHR National Phenome Centre, Department of Surgery and Cancer, Imperial College London , Hammersmith Hospital Campus, London W12 0NN, United Kingdom
| | - Anisha Wijeyesekera
- Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London , South Kensington Campus, London SW7 2AZ, United Kingdom
| | - Elaine Holmes
- Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London , South Kensington Campus, London SW7 2AZ, United Kingdom.,MRC-NIHR National Phenome Centre, Department of Surgery and Cancer, Imperial College London , Hammersmith Hospital Campus, London W12 0NN, United Kingdom
| |
Collapse
|
9
|
Wijesooriya K, Liyanage N, Kaluarachchi M, Sawkey D. SU-F-T-658: Out-Of-Field Dose Comparison for TrueBeam Low Energy Beams for Extended Distances: Measurement Vs Monte Carlo Simulation. Med Phys 2016. [DOI: 10.1118/1.4956844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
10
|
Ackroyd M, Prior S, Whitmore C, Kaluarachchi M, Muntoni F, Brown S. EM.P.2.10 Deficiency of multiple alpha dystroglycan ligand interactions underlie the phenotype of a FKRP-deficient mouse model for muscle eye brain disease. Neuromuscul Disord 2009. [DOI: 10.1016/j.nmd.2009.06.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
11
|
Ackroyd M, Skordis L, Kaluarachchi M, Prior S, Muntoni F, Brown S. G.P.2.10 Characterisation of the brain and eye phenotype of a FKRP knock-down mouse model of Muscle–Eye–Brain disease. Neuromuscul Disord 2008. [DOI: 10.1016/j.nmd.2008.06.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
12
|
Ackroyd MR, Skordis L, Kaluarachchi M, Godwin J, Prior S, Fidanboylu M, Piercy RJ, Muntoni F, Brown SC. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies. Brain 2008; 132:439-51. [DOI: 10.1093/brain/awn335] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
13
|
Muntoni F, Brockington M, Godfrey C, Ackroyd M, Robb S, Manzur A, Kinali M, Mercuri E, Kaluarachchi M, Feng L, Jimenez-Mallebrera C, Clement E, Torelli S, Sewry CA, Brown SC. Muscular dystrophies due to defective glycosylation of dystroglycan. Acta Myol 2007; 26:129-135. [PMID: 18646561 PMCID: PMC2949305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Muscular dystrophies are a clinically and genetically heterogeneous group of disorders. Until recently most of the proteins associated with muscular dystrophies were believed to be proteins of the sarcolemma associated with reinforcing the plasma membrane or in facilitating its re-sealing following injury. In the last few years a novel and frequent pathogenic mechanism has been identified that involves the abnormal glycosylation of alpha-dystroglycan (ADG). This peripheral membrane protein undergoes complex and crucial glycosylation steps that enable it to interact with LG domain containing extracellular matrix proteins such as laminins, agrin and perlecan. Mutations in six genes (POMT1, POMT2, POMGnT1, fukutin, FKRP and LARGE) have been identified in patients with reduced glycosylation of ADG. While initially a clear correlation between gene defect and phenotype was observed for each of these 6 genes (for example, Walker Warburg syndrome was associated with mutations in POMT1 and POMT2, Fukuyama congenital muscular dystrophy associated with fukutin mutations, and Muscle Eye Brain disease associated with POMGnT1 mutations), we have recently demonstrated that allelic mutations in each of these 6 genes can result in a much wider spectrum of clinical conditions. Thus, the crucial aspect in determining the phenotypic severity is not which gene is primarily mutated, but how severely the mutation affects the glycosylation of ADG. Systematic mutation analysis of these 6 glycosyltransferases in patients with a dystroglycan glycosylation disorder identifies mutations in approximately 65% suggesting that more genes have yet to be identified.
Collapse
Affiliation(s)
- F Muntoni
- Dubowitz Neuromuscular Centre, Department of Paediatrics, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Ackroyd M, Kaluarachchi M, Skordis L, Piercy R, Godwin J, Muntoni F, Brown S. C.P.3.15 A new mouse model for dystroglycanopathies associated with mutations in FKRP. Neuromuscul Disord 2007. [DOI: 10.1016/j.nmd.2007.06.375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
15
|
Motsch I, Kaluarachchi M, Emerson LJ, Brown CA, Brown SC, Dabauvalle MC, Ellis JA. Lamins A and C are differentially dysfunctional in autosomal dominant Emery-Dreifuss muscular dystrophy. Eur J Cell Biol 2005; 84:765-81. [PMID: 16218190 DOI: 10.1016/j.ejcb.2005.04.004] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Mutations in the LMNA gene, which encodes nuclear lamins A and C by alternative splicing, can give rise to Emery-Dreifuss muscular dystrophy. The mechanism by which lamins A and C separately contribute to this molecular phenotype is unknown. To address this question we examined ten LMNA mutations exogenously expressed as lamins A and C in COS-7 cells. Eight of the mutations when expressed in lamin A, exhibited a range of nuclear mislocalisation patterns. However, two mutations (T150P and delQ355) almost completely relocated exogenous lamin A from the nuclear envelope to the cytoplasm, disrupted nuclear envelope reassembly following cell division and altered the protein composition of the mid-body. In contrast, exogenously expressed DsRed2-tagged mutant lamin C constructs were only inserted into the nuclear lamina if co-expressed with any EGFP-tagged lamin A construct, except with one carrying the T150P mutation. The T150P, R527P and L530P mutations reduced the ability of lamin A, but not lamin C from binding to emerin. These data identify specific functional roles for the emerin-lamin C- and emerin-lamin A- containing protein complexes and is the first report to suggest that the A-type lamin mutations may be differentially dysfunctional for the same LMNA mutation.
Collapse
Affiliation(s)
- Isabell Motsch
- The Randall Division of Cell and Molecular Biophysics, Kings College, New Hunts House, Guy's Campus, London SE1 1UL, UK
| | | | | | | | | | | | | |
Collapse
|